プログラム

第三届国际病毒性肝炎论坛日程(中国・成都)

The 3rd International Symposium on Viral Hepatitis (Chengdu, China)
June 27 2016 (Monday)
Opening Ceremony (Chaired by Hong Tang, West China Hospital of Sichuan University)
大会开幕
(唐红主任主持, 四川大学华西医院)
8:30-9:00 Yong Zeng, Vice president of West China Hospital of Sichuan University四川大学华西医院曾勇副院长致欢迎词
Shuichi Kaneko, Dean of Kanazawa University Graduate School of Medical Sciences日本金沢大学研究生院院长金子周一教授致辞
Ying-Ru Lo, Coodinator of WHO Regional Office for the Western Pacific世界卫生组织西太平洋区域办事处卢颖如教授致辞
Ji Shen,Director of Health and Family Planning Commission of Sichuan Province, Director of Sichuan Medical Association
四川省卫生和计划生育委员会主任、四川省医学会会长沈骥教授致辞
Session 1 (第一部分)
Chairs
主持人
Shuichi Kaneko, Dean of Kanazawa University Graduate School of Medical Sciences, Head of Liver Centre, Kanazawa University Hospital
金子周一,日本金沢大学研究生院院长,日本金沢大学医院肝脏中心主任
Lan Zhang, Chief Medical Officer, China Foundation for Hepatitis Prevention & Control 张岚,中国肝炎防治基金会技术总监
9:00-9:25 WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection
世界卫生组织《丙型肝炎患者筛查、关护和治疗指南》解读
Azumi Ishizaki
WHO Geneva headquater
世界卫生组织日内瓦总部
9:25-9:50 The WHO global and regional viral hepatitis strategy世界卫生组织全球及区域病毒性肝炎应对策略
WHO hepatitis B guideline: adapting to the country context世界卫生组织乙型病毒性肝炎指南:面对不同国情的战略调整
Ying-Ru Lo卢颖如
WPRO世界卫生组织西太平洋区域办事处
9:50-10:15 Investing in and financing hepatitis B and C treatment in China
中国乙型和丙型病毒性肝炎治疗的援助计划
Po-Lin Chan曾宝玲
WHO Country Office - China
世界卫生组织驻华办事处
10:15-10:30 Q&A(讨论)
10:30-10:40 Tea break茶歇(10分钟)
Session 2 (第二部分)
Chairs

主持人

Bingjun Lei, Professor of Centre of Infectious Diseases, West China Hospital雷秉钧,四川大学华西医院感染性疾病中心教授
Yilan Zeng,Vice Dean of Chengdu Pulic Health Clinical Centre 曾义岚,成都市公共卫生临床医疗中心副院长
Ta Thanh Van, Vice President of Hanoi Medical University越南河内医科大学副校长
10:40-11:05 Co-infection of HIV and hepatitis viruses
人类免疫缺陷病毒合并肝炎病毒感染的临床研究
Azumi Ishizaki
Kanazawa University
日本金沢大学
11:05-11:30 Current antiviral therapy for chronic hepatitis in Japan
日本病毒性肝炎的抗病毒治疗现状
Kawaguchi Kazunori
Kanazawa University
日本金沢大学
11:30-11:55 Check-up for hepatitis patients in Japan
日本病毒性肝炎患者的随访方案
Shimakami Tetsuro
Kanazawa University
日本金沢大学
11:55-12:10 Q&A(讨论)
12:10-14:00 Lunch(午餐)
Session 3 (第三部分)
Chairs
主持人
Liansan Zhao, Professor of Centre of Infectious Diseases, West China Hospital赵连三,华西医院感染性疾病中心教授
Pham Van Thuc, Dean of Haiphong Medical University and Affiliated Hospital越南海防医科大学附属医院院长
Davaadorj Duger, Vice Dean for clinical affairs of Mongolian National University of Medical Sciences蒙古国立医科大学临床事务副院长
14:00-14:25 What can we learn from Hepatitis B control in China
中国乙型病毒性肝炎的防控启示
Fuqiang Cui(崔富强
China CDC
中国疾病预防控制中心
14:25-14:50 Treatment strategy of chronic hepatitis B in China
中国乙型病毒性肝炎的治疗策略
Jinlin Hou侯金林
Southern Medical University南方医科大学南方医院
14:50-15:15 Hepatitis C prevalence and control strategies in China
中国丙型肝炎流行状况及防治策略
Xiaochun Wang (王晓春)
China CDC
中国疾病预防控制中心
15:15-15:30 Q&A(讨论)
15:30-15:40 Tea break 茶歇(10分钟)
Session 4 (第四部分)
Chairs
主持人
Ping Feng, Vice Director of Centre of Infectious Diseases, West China Hospital冯萍,四川大学华西医院感染性疾病中心副主任
Tsendsuren Oyunsuren, Head of Laboratory of Molecular Biology, Mongolian Academy of Sciences蒙古科学院分子生物学实验室主任
15:40-16:05 The distribution of HBV, HCV genotypes among intravenuos drug users (IDU) and female sex workers (FSW) in Haiphong, Vietnam
越南海防市静脉吸毒人员及女性性工作者乙型肝炎/丙型肝炎病毒基因型分布调查
Hung Cuong Nguyen
HPMU
越南海防医药大学
16:05-16:30 HBV and HCV infected patient treatment in Vietnam
越南慢性乙型/丙型病毒性肝炎的治疗策略
Tran Ngoc Anh
Hanoi Medical University
越南河内医科大学
16:30-16:55 Effectiveness and safety of sofosbuvir/ledispasvir treatment for monoinfected HCV patients in Mongolia
索非布韦/雷迪帕维治疗蒙古丙型肝炎患者的疗效与安全性
Ariuna Sumiyadorj
MNUMS
蒙古国立医科大学
16:55-17:10 Q&A(讨论)
17:10 Closing of Day 1第一天会议结束
June 28 2016 (Tuesday)
Session 1 (第一部分)
Chairs
主持人
Cunliang Deng, Vice Dean of the affiliated hospital of Luzhou Medical College邓存良,西南医科大学附属医院副院长
Xuezhong Lei, Vice Director of Centre of Infectious Diseases, West China Hospital雷学忠,四川大学华西医院感染性疾病中心副主任
8:30-8:55AM Treatment strategy of chronic Hepatitis C in China
中国丙型病毒性肝炎的治疗策略
Lai Wei (魏来)
Peking University
北京大学人民医院
8:55-9:20AM Innate immunity during HCV infection
丙型肝炎病毒感染过程中的固有免疫
Honda Masao
Kanazawa University
日本金沢大学
9:20-9:45AM The verification of HBV RNA and its potential clinical significance
HBV RNA的确证及潜在临床意义探究
Fengmin Lu鲁凤民
Peking University
北京大学基础医学院
9:45-10:10AM Research on Hepatitis B Virus X protein (HBx): Overview and Recent Progress
乙型肝炎病毒X蛋白(HBx)研究概况和最新进展
Seishi Murakami村上清史
Kanazawa University
日本金沢大学
10:10-10:25AM Q&A(讨论)
10:25-10:35AM Tea break茶歇(10分钟)
Session 2 (第二部分)
Chairs
主持人
Liangshi Xiong, Director of Department of Infectious Diseases, North Sichuan Medical College熊良仕,川北医学院感染科主任
Xiaoju Lü, Vice Director of Centre of Infectious Diseases, West China Hospital吕晓菊,四川大学华西医院感染性疾病中心副主任
10:35-11:00 Bio-inspired detoxification using 3D-engneered devices
3D打印技术在生物解毒方面的应用研究
Malin Gou(苟马玲)
Sichuan University
生物治疗国家重点实验室
11:00-11:25 HBV X gene integration and HBV/HDV double infection in HCC patients in Mongolia
蒙古原发性肝癌患者乙型/丁型肝炎病毒重叠感染及乙型肝炎病毒X基因整合的临床研究
Lkhagvasuren Damdindorj
Mongolian Academy of Science 蒙古科学院
11:25-11:50 A HBV cccDNA model for functional study and drug development
基于HBV cccDNA模型的功能研究及药物开发
Feng Li李锋)
University of North Carolina
美国北卡大学
11:50-12:05 Q&A(讨论)
12:05-14:00 Lunch (午餐)
Session 3 (第三部分)
Chairs
主持人
Hong Tang,Director of the Centre of Infectious Diseases, West China Hospital 唐红,四川大学华西医院感染性疾病中心主任
Tran Ngoc Anh, Associate Professor of Hanoi Medical University越南河内医科大学副教授
14:00-14:25 Role of scaffold protein JSAP in cancer
支架蛋白JASP在肿瘤发生中的作用
Yoshioka Katsuji
Kanazawa University
日本金沢大学
14:25-14:50 Interplay between stromal and epithelial cells, increased complexity in tumor microenvironment for carcinogenesis
基质细胞与上皮细胞之间的相互作用增加肿瘤微环境的复杂性
Yong Lin林勇
Lovelace Institute, USA
美国Lovelace研究所
14:50-15:15 Upregulating TNC expression promotes hepatoma cell metastasis and is associated with poor prognosis in HCC patients
TNC高表达与肝癌转移及预后的关系
Lang Bai(白浪
West China Hospital
四川大学华西医院
15:15-15:30 Q&A(讨论)
15:30:15:40 Tea break茶歇(10分钟)
Session 4 (第四部分)
Chairs
主持人
Tetsuro Shimakami, Assistant Professor of Kanazawa University 日本金沢大学助理教授
Kazunori Kawaguchi, Associate Professor of Kanazawa University 日本金沢大学副教授
15:40-16:00 Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems
丙型肝炎病毒细胞复制模型中miR-122拮抗剂联合直接抗病毒药物可有效抑制病毒复制
Fanwei Liu (刘范伟)
Kanazawa University
日本金沢大学
16:00-16:20 HBV-induced high expression of endoplasmic reticulum proteins in hepatocarcinogenesis and prognosis
HBV诱导的内质网蛋白高表达促进肝细胞癌发生并影响预后
Lingyao Du (杜凌遥
West China Hospital
四川大学华西医院
16:20-16:40 Hepatitis B virus X protein stimulates HBV replication by regulating transcription factors associated with DNA or histone methylation
乙型肝炎病毒X蛋白通过调节DNA或组蛋白甲基化相关转录因子促进HBV复制
Xuyang Wang王旭阳
Kanazawa University
日本金沢大学
16:40-17:00 Roles and mechanism of Hepatitis B virus X protein in HBV replication and pathogenesis
乙型肝炎病毒X蛋白在HBV复制及致病性中的作用及机制研究
Libo Yan (严丽波
West China Hospital
四川大学华西医院
17:00-17:20 Q&A(讨论)
17:20-17:40 Closing remarks of the symposium(大会闭幕)
Shuichi Kaneko
, Dean of Kanazawa University Graduate School of Medical Sciences日本金沢大学研究生院院长金子周一教授讲话
Hong Tang , Director of the Centre of Infectious Diseases, West China Hospital四川大学华西医院感染性疾病中心主任唐红教授讲话
ページトップへ